Vanderbilt University Medical Center: Targeting Calcium Handling in A-Fib
June 09, 2023
June 09, 2023
NASHVILLE, Tennessee, June 9 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Atrial fibrillation (A-fib) -- the most common cardiac arrhythmia (irregular heartbeat) -- is associated with increased risk of stroke, heart failure, dementia and death. Antiarrhythmic drug therapy to prevent A-fib has remained elusive.
The strongest genetic risk factors for A-fib in humans are variants in a chromosomal region including the gene Pitx2. Mice with Pi . . .
Atrial fibrillation (A-fib) -- the most common cardiac arrhythmia (irregular heartbeat) -- is associated with increased risk of stroke, heart failure, dementia and death. Antiarrhythmic drug therapy to prevent A-fib has remained elusive.
The strongest genetic risk factors for A-fib in humans are variants in a chromosomal region including the gene Pitx2. Mice with Pi . . .